Literature DB >> 31980746

Differences in the association of diet quality with body fat distribution between men and women.

Gertraud Maskarinec1, Lisa A Namatame2, Minji Kang2, Steven D Buchthal2, Thomas Ernst3, Kristine R Monroe4, John A Shepherd2, Lynne R Wilkens2, Carol J Boushey2, Loïc Le Marchand2, Unhee Lim2.   

Abstract

BACKGROUND/
OBJECTIVE: As dietary intake and endocrine metabolism are vastly different by sex, we evaluated differences in the association of diet quality with body composition between men and women. SUBJECTS/
METHODS: Close to 2000 participants from the Multiethnic Cohort completed calibrated quantitative food frequency questionnaires at cohort entry (1993-96) and clinic visit (2013-16), from which the Healthy Eating Index (HEI-2010) was computed. Adiposity measures were obtained through DXA and MRI at clinic visit. Multivariable-adjusted mean adiposity measures were estimated by tertiles of HEI-2010 scores using general linear regression. The associations of diet quality with high visceral fat (VAT) and nonalcoholic fatty liver disease (NAFLD) were examined by logistic regression. To assess sex differences, cross-product terms with the HEI-2010 were added to the models.
RESULTS: Mean HEI-2010 scores were higher for women than men at cohort entry (67.4 vs. 64.0) and clinic visit (73.6 vs. 71.0). Past and current diet quality was inversely associated with adiposity measures in men and women. Although interaction terms were not significant, the magnitude of the slopes and differences in adjusted means across tertiles suggested a stronger association for women than men. When comparing individuals who maintained a high vs. poor quality diet over 20 years, women but not men showed significantly lower risks for high VAT, whereas high HEI-2010 scores predicted a lower risk of NAFLD in both sexes.
CONCLUSIONS: The inverse association of diet quality with adiposity was similar in both sexes, but diet quality appeared to have a stronger influence on VAT in women than men.

Entities:  

Mesh:

Year:  2020        PMID: 31980746      PMCID: PMC7377951          DOI: 10.1038/s41430-020-0563-1

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.884


INTRODUCTION

The importance of considering sex as a biological variable in animal and human studies has been highlighted in recent years as it becomes clear that disease etiology and treatment effects may differ between men and women [1]. In nutritional studies, the assessment of long-term dietary intake as a risk factor for chronic diseases poses an additional problem. If sex differences in portion sizes and other aspects of food consumption are not accurately captured, the validity of the findings by sex are challenged [2]. A comparison of eating patterns between men and women has indicated that, in general but not for all foods, portions consumed by men were larger than those by women [3-5]. For food choices, differences between men and women have been reported, e.g., women eat more fruits, vegetables, cereals, milk and dairy products than men do, while men consume more meat products, eggs, alcohol, and various starchy foods than women [6, 7]. We previously observed in the Multiethnic Cohort (MEC) that women tended to have better diet quality as assessed by the HEI-2010 [8], a measure of adherence to U.S. Dietary Guidelines for Americans, which are updated every 5 years but the principles in scoring essential food groups remain the same [9], than men [10]. Obesity, a risk factor for many types of chronic diseases including cancer, is rising at alarming rates worldwide [11]. The adverse consequences of excess body fat depend on its properties: visceral adipose tissue (VAT) and liver fat are more likely to be associated with the metabolic syndrome [12] and other serious consequences than subcutaneous adipose tissue (SAT) [13, 14]. In the Adiposity Phenotype Study (APS), conducted among a subset of the MEC, we demonstrated that maintaining a high quality diet during mid-to-late adulthood might prevent the accumulation of VAT and liver fat [15]. As it is not known whether the association between the HEI-2010 and adiposity measures differs by sex, the objective of the current analysis is to compare the association of diet quality as assessed by the HEI-2010 with different adiposity measures between men and women in the APS.

Methods

Study Population.

The APS participants were recruited from the MEC, a continuing prospective study in Hawaii and Los Angeles, California, which examines diet, lifestyle, and genetic risk factors for cancer. The MEC consisted of more than 215,000 men and women from five ethnic groups aged 45–75 years at the time of enrollment in 1993–1996. All participants completed a 26-page baseline questionnaire by mail [16]. Participants aged 60–72 years as of January 2013 and of good general health were targeted for stratified recruitment by sex, ethnicity and six BMI categories during 2013–16 [15]. Mailed invitations and screening telephone calls identified eligible participants among 13,884 participants [17]. Due to the strict eligibility criteria and the requirement to travel to a clinic for imaging, the response rate was only 15.6%, resulting in a sample size of 1,861. Eligible cohort members visited study clinics to take part in anthropometric measurements, DXA and MRI imaging, fasting blood sample collection, and questionnaires. The protocols were approved by the Institutional Review Boards at UH (CHS# 17200) and USC (#HS-12–00623); all participants provided informed signed consent.

Dietary Assessment.

In addition to questions about demographics, medical conditions, physical activity, and other lifestyle factors, all participants completed a quantitative food frequency questionnaire (QFFQ) containing over 180 food items at cohort entry and clinic visit [16]. With the help of images, they reported the frequency and serving size of the items they consumed in their usual diet during the previous year. Although no true validation study was performed, a calibration sub-study found acceptable correlations between the QFFQ and three 24-hour dietary recalls among 1,606 cohort members; mean correlations ranged from 0.57–0.74 for nutrient densities [18]. Although the essence of the QFFQ remained the same to allow comparison of broad lists of food groups that remain constant over 20 years, the original QFFQ was updated in 2003 for use in the MEC-APS to change the food lists, amounts, and examples or names given for the food items. To assess regular intake, food composition tables and a large recipe database were created specifically for the MEC [19]. Scores (0–100) were computed from the QFFQ data at cohort entry and clinic visit according to the Healthy Eating Index-2010 (HEI-2010) and were categorized into tertiles based on the total study population at each point in time [9, 20]. As a result, tertile boundaries were different at cohort entry and clinic visit. To incorporate diet quality at both points in time, the HEI-2010 scores at cohort entry and at clinic visit were dichotomized into low and high levels using the median of the respective distributions. The categories for the two time points were combined into a four-level variable (low/low, low/high, high/low, high/high) describing each participant’s diet quality at cohort entry and clinic visit, e.g., low/high designates a score below the median at cohort entry and a score above the median at clinic visit. In addition, change in HEI-2010 from cohort entry to clinic visit was calculated as a continuous variable. Daily Metabolic Equivalent of Tasks (METs) were calculated from sleep duration and physical activity levels.

Imaging.

As described previously [17], a whole-body DXA scan (Hologic Discovery A at UH and USC) was used to measure total and regional body composition at clinic visit. To assess localized VAT and SAT areas at the four cross-sectional lumbar sites (L1-L2, L2-L3, L3-L4, L4-L5), abdominal MRI scans were obtained on 3-Tesla scanners (Siemens TIM Trio, Erlangen, Germany, software version VB13 at UH; General Electric HDx, Milwaukee, WI, software release 15M4 at USC) using an axial gradient-echo sequence with water-suppression and breath-holds (25 slices, 10 mm thickness, 2.5 mm gap, TR/TE=140/2.6 ms, 70° flip angle). Non-alcoholic fatty liver disease (NAFLD) as assessed from the MRI images was defined as >5.5% among men consuming <30 g/day ethanol and women with <20 g/day ethanol and visceral obesity as ≥150 cm2 mean visceral fat area (high VAT). Percent liver fat was estimated from a series of axial triple gradient-echo Dixon-type scans (10 mm slices, no gap, TE=2.4, 3.7 and 5.0 ms, TR=160 ms, 25° flip angle) by measuring and analyzing in-phase, out-of-phase, and in-phase signals in a manually placed circle that did not include hepatic veins or biliary ducts [15].

Statistical Analysis.

In addition to BMI, two DXA-derived measures (DXA total and trunk fat) and several MRI-based measures (mean VAT area for L1-L5, VAT/SAT ratio, percent liver fat, NAFLD, and high VAT) were analyzed in relation to the HEI-2010. Covariate-adjusted mean adiposity measures by tertiles of the HEI-2010 were estimated using general linear models separately for men and women. Trend tests were performed to evaluate dose-response relations with dietary index scores as continuous variables. In addition to ethnicity and age, total energy intake (log-transformed to meet model assumptions), physical activity (high vs. low using the median of METs), and alcohol intake at the time of dietary assessment were included as covariates in all models. In the models for trunk fat, VAT, VAT/SAT ratio, and percent liver fat, DXA total body fat was also included. To assess the relation of change in diet quality from cohort entry to clinic visit, we modelled change of HEI-2010 (continuous per 10 units) as predictor of high VAT and NAFLD while adjusting for diet quality at cohort entry. To estimate odds ratios (OR) and 95% CI for the presence of NAFLD and high VAT based on diet quality at cohort entry and clinic visit using the four-level variable, logistic regression was applied using the same covariates as above, first for the entire study population and then stratified by ethnicity. To assess effect modification by sex, a main effect for sex and an interaction term of sex with the HEI-2010 were added to the models combining men and women. Differences across ethnic groups were explored through interaction terms. Due to missing values and excluding all high-alcohol drinkers for NAFLD analysis (N=57 diet at cohort entry and N=36 at clinic visit, N=21 for DXA and N=60 for MRI), the different models varied slightly in number of participants.

RESULTS

This study included 923 men and 938 women from 5 ethnic backgrounds: white, African American, Native Hawaiian, Japanese American, and Latino (Table 1). The mean ages at cohort entry were 48.5 ± 2.6 (range: 45.0–57.0) years for men and 48.2 ± 2.5 (range: 45.0–56.0) years for women, while the respective values at clinic entry were 69.3±2.8 (range: 61.4–77.4) years for men and 69.1 ± 2.7 (range: 59.9–77.0) years for women with respective follow-up times of 20.8 ± 1.2 and 21.0 ± 1.2 years.
Table 1.

Study Population by Sex at Cohort Entry (1993–96) and Clinic Visit (2013–2016)[a]

Characteristic[b]AllMenWomen
Number1861923938
EthnicityWhite411 (22)214 (23)197 (21)
African American317 (17)133 (14)184 (20)
Native Hawaiian307 (17)145 (16)162 (17)
Japanese American434 (23)230 (25)204 (22)
Latino392 (21)201 (22)191 (20)
Age, yrsCohort entry48.3±2.548.5±2.648.2±2.5
Clinic visit69.2±2.769.3±2.869.1±2.7
BMI, kg/m2Cohort entry26.1±4.226.4±3.725.7±4.6
Clinic visit28.0±4.827.9±4.428.1±5.2
Physical activity, METsCohort entry1.6±0.31.6±0.31.6±0.3
Clinic visit1.6±0.31.7±0.31.6±0.3
Alcohol intake, drinks/dayCohort entry0.7±1.41.0±1.80.4±0.8
Clinic visit0.7±1.61.0±1.90.4±1.0
Total energy,Cohort entry2224±10282484.8±10692062.2±982
KcalClinic visit1883±94620354±9681729.6±899
HEI-2010Cohort entry65.7±10.664.0±10.667.4±10.5
Clinic Visit72.7±9.671.0±11.073.6±10.0
Change6.6±10.57.2±10.96.1±10.1
HEI-2010 over time[c]Low/Low616359257
Low/High292158134
High/Low297138159
High/High622253369
Body compositionClinic Visit (only)
Total body fat, kg25.5±8.723.1±7.727.8±8.9
Trunk fat, kg13.5±4.812.9±4.714.1±4.8
VAT area (L1–L5 mean), cm2168±84202±90135±62
VAT/SAT ratio0.8±0.51.1±0.50.5±0.2
Percent liver fat, %5.7±4.65.6±4.45.7±4.8
High VAT (≥150 cm2), %52.970.036.4
Nonalcoholic liver disease (>5.5%), %33.433.633.1

Means ± standard deviations or numbers (%) are shown

Missing values: 57 for diet at cohort entry, 36 for diet at clinic visit, 21 for DXA, 60 for MRI

HEI-2010 scores were divided at the median, i.e., Low/Low=scores below median at cohort entry (1993–96) and clinic visit (2013–2016); Low/High=scores below median at cohort entry and above median at clinic visit; High/Low=scores above median at cohort entry and below median at clinic visit; High/High=scores above median at cohort entry and clinic visit.

Mean HEI-2010 scores were approximately 3 points higher for women than men at cohort entry (67.4 vs. 64.0) and at clinic visit (73.6 vs. 71.0). Therefore, men were more likely to be in the lowest and women more likely to be in the highest tertile. However, for both groups the scores increased over time: by 7.2 ± 10.9 and 6.1 ± 10.1 points for men and women, respectively. There was little difference in physical activity, but men reported higher intakes of total energy and alcohol than women. BMI increased from cohort entry to clinic visit from 26.4 ± 3.7 kg/m2 to 27.9 ± 4.4 kg/m2 in men with a difference of 1.4 ± 3.0 kg/m2. In women, BMI was 25.7 ± 4.6 kg/m2 at cohort entry and 28.1 ± 5.2 kg/m2 at clinic entry with a difference of 2.3 ± 3.7 kg/m2. Women, compared to men, had higher amounts of total body fat (27.8 ± 8.9 kg vs. 23.1 ± 7.7 kg) and trunk fat (14.1 ± 4.8 vs. 13.5 ± 4.8 kg). However, VAT (201.6±89.5 cm2) and the VAT/SAT ratio (1.1±0.5) were greater in men than in women (134.6 ± 61.6 cm2 and 0.5±0.2). Percent liver fat (5.7 ± 4.8% vs 5.6 ± 4.4%) differed little by sex. As indicated by the significant p-values of the regression coefficients, all adiposity measures were inversely associated with diet quality showing lower values among participants with HEI-2010 scores in the highest vs. the lowest tertile (Table 2). Although none of interactions between sex and the HEI-2010 except for BMI at clinic visit were statistically significant, the magnitude of the regression coefficients and the greater differences across extreme tertiles suggested that women experienced stronger associations of the HEI-2010 with several adiposity measures than men. In particular, the respective VAT/SAT ratios for men and women at clinic visit was 8% and 23% lower in the top vs. bottom tertile; the corresponding values for NAFLD were 27% and 44%. In general, the results at cohort entry were quite similar to those at clinic visit.
Table 2.

Mean Adiposity Measures by Tertiles of Diet Quality at Cohort Entry (1993–1996) & Clinic Visit (2013–2016) Stratified by Sex[a]

Cohort EntryClinic Visit
Adiposity measureTN[b]MenN[b]WomenP[e]TN[b]MenN[b]WomenP[e]
Mean95% CLMean95% CLMean95% CLMean95% CL
Body mass index, kg/m231–6136928.227.7, 28.625129.028.4, 29.60.1035–6834828.728.3, 29.226129.228.6, 29.80.01
61–7131127.827.3, 28.331028.127.5, 28.668–7829027.727.2, 28.231928.728.1, 29.2
71–9224327.426.9, 28.037727.426.8, 27.978–9927026.926.4, 27.433926.726.2, 27.2
β (P-value)−0.023 (0.11)−0.063 (0.0001)−0.063 (<0.0001)−0.113 (<0.0001)
Total body fat, kg31–6136523.722.9, 24.424728.727.7, 29.70.5735–6834424.623.9, 25.425729.428.5, 30.40.11
61–7130923.122.3, 23.930727.927.0, 28.868–7828522.621.8, 23.431628627.8, 29.4
71–9223722.321.4, 23.237526.926.1, 27.778–9926721.620.8, 22.433725.724.9, 26.5
β (P-value)−0.039 (0.09)−0.072 (0.005)−0.111 (<0.0001)−0.166 (<0.0001)
Trunk fat[c], kg31–6136113.012.9, 13.123914.314.1, 14.50.5035–6834113.012.8, 13.124814.314.1, 14.50.99
61–7130612.812.7, 13.030114.214.0, 14.468–7828212.812.7, 13.030814.214.0, 14.4
71–9222412.712.5, 12.936413.913.7, 14.178–9925412.712.6, 12.933014.013.8, 14.1
β (P-value)−0.007 (0.07)−0.015 (0.005)−0.008 (0.08)−0.020 (0.0003)
VAT(L1–L5 mean)[c], cm231–61358206199, 212245145139, 1510.6035–68329206198, 212254144138, 1490.28
61–71297205197, 212304136131, 14168–78286206199, 213312140135, 145
71–92231192184, 200366126122, 13178–99256193186, 201330123118, 128
β (P-value)−0.415 (0.04)−0.654 (<0.0001)−0.468 (0.02)−0.889 (<0.0001)
VAT/SAT ratio[c]31–613581.141.09, 1.192450.590.57, 0.620.9535–683291.131.08, 1.182540.590.56, 0.620.78
61–712971.121.07, 1.183040.550.52, 0.5768–782861.151.10, 1.203120.570.54, 0.59
71–922311.050.98, 1.113660.500.48, 0.5378–992561.040.99, 1.103300.490.46, 0.51
β (P-value)−0.003 (0.09)−0.003 (<0.0001)−0.003 (0.03)−0.004 (<0.0001)
Percent liver fat[c,d], %31–613546.135.70, 6.562466.626.03, 7.200.6135–683266.125.67, 6.572566.706.14, 7.250.74
61–712965.464.99, 5.933035.695.17, 6.2068–782825.795.32, 6.273086.145.64, 6.64
71–922305.114.58, 5.653615.224.74, 5.7078–992574.884.38, 5.383274.674.18, 5.17
β (P-value)−0.047 (0.0005)−0.052 (0.0006)−0.054 (<0.0001)−0.069 (<0.0001)

General linear models were used to obtain means adjusted for age, ethnicity, alcohol intake, total energy intake (log-transformed), and physical activity at clinic visit

Missing values: 57 for diet at cohort entry (1993–96), 36 for diet at clinic visit, 21 for DXA, 60 for MRI (2013–2016)

Adjusted for total body fat at clinic visit

Liver fat was log-transformed

Obtained from interaction terms between sex and continuous HEI-2010 score.

In logistic regression models that considered the combination diet quality at cohort entry and clinic visit (Figure 1), the global interaction terms of sex with diet quality were p=0.12 for high VAT and p=0.95 for NAFLD. The risk estimates for high VAT were statistically significantly lower for women who had high HEI-2010 scores at both times (high/high); the respective ORs for low/high, high/low, and high/high status as compared to low/low (Figure 1B) were 0.53 (95% Cl, 0.31–0.92), 0.52 (95% Cl, 0.32–0.87), and 0.39 (95% Cl, 0.26–0.59). On the other hand, no significant associations between the combined HEI-2010 status and high VAT were seen among men (Figure 1A). For NAFLD (Figures 1C and 1D), the associations in men and women were similar. Only participants with a high quality diet at both assessment times were significantly less likely to have NAFLD with similar risk estimated in men (OR=0.49; 95% Cl, 0.32–0.75) and women (OR=0.52; 95% Cl, 0.35–0.78). In models with change in HEI-2010 from cohort entry to clinic visit, the stronger influence of improvement in diet quality over time among women than men was confirmed. The respective ORs for high VAT were 0.88 (95% Cl, 0.71–1.10) and 0.77 (95% Cl, 0.63–0.95) in men and women, while the corresponding values for NAFLD were 0.86 (OR=0.86; 95% Cl, 0.72–1.03) and 0.76 (95% Cl, 0.62–0.92). The interaction terms of high VAT and NAFLD with sex were not significant in any of the five ethnic groups (data not shown).
Figure 1.

Association of Diet Quality at Cohort Entry (1993–96) and Clinic Visit (2013–2016) with High VAT and NAFLD by Sexa

DISCUSSION

In a cross-sectional analysis at the time of clinic visit, men and women showed statistically significant differences in diet quality scores and all adiposity measures except liver fat. In general, higher diet quality as assessed by the HEI-2010 was related to lower adiposity values for men and women. However, women generally showed stronger associations than men. For example, women in the highest tertile of diet quality had a 23% lower VAT/SAT ratio as compared to the lowest tertile while the difference for men was only 8%. In an analysis of combined HEI-2010 status at clinic visit and at cohort entry 20 years earlier, women were significantly less likely to develop high VAT if they scored above the median HEI-2010 at one or both times or improved their score over time. However, in men no significant associations were seen with improved diet quality. Both men and women were less likely to develop NAFLD if they scored above the median HEI-2010 at both time points. As in previous investigations, men in the APS generally consumed more total energy, reported lower diet quality [10], and had less total body fat and more VAT than women but similar NAFLD [17, 21, 22]. Although diet quality associations with different adiposity phenotypes have been reported previously [15, 23–25], few studies have addressed sex differences of these relations. A German study examined dietary components and reported effect modification by sex for a posteriori patterns, e.g., a negative association with VAT was seen for fiber and carbohydrates from cereals in men but not women [26]. Yet, another analysis did not detect any effect modification for the relation of 14 food groups with various adiposity tissues [27]. Men and women in the MEC have shown similar associations of high diet quality with disease outcomes, e.g., mortality [20] and type 2 diabetes [28]. Looking at biomarkers, the association between diet quality and carotenoids was also similar in men and women [29], but mortality associated with higher γ-tocopherol levels was only elevated in women and not in men [30]. Strengths of the current study include the long follow-up time of 20 years since cohort entry providing dietary information at two points in time. State-of-the-art methods were applied to assess total body composition by DXA and MRI imaging. The QFFQ was specifically designed for a multiethnic population to capture diverse foods. However, several limitations need to be considered. As the QFFQ was only calibrated and not validated using a gold standard, the dietary assessment and the HEI-2010 may not have completely captured the true diet of the participants. The relation between diet quality and adiposity at clinic visit cannot be interpreted as causal although the significant associations between diet quality at cohort entry and adiposity measures 20 years later indicate the possibility that diet quality may influence body fat distribution over a long time. As the sample sizes for ethnic-specific analyses were very limited, no ethnic specific models were presented. The limited age-range of the study sample may have affected our results, as the relation may be stronger in younger individuals before onset of chronic conditions may affect dietary habits and/or body fat distribution. The question whether diet quality is better and associations with adiposity measures are stronger among women than men is difficult to explain. Besides being a chance finding, it is possible that women report their diet more accurately or that portion sizes in the QFFQ are closer to those consumed by women than men as suggested previously [5]. Given the similar magnitude of the associations between a high quality diet and chronic disease incidence and mortality in both sexes [20, 31], the large differences in VAT and the VAT/SAT ratio between men and women are probably due to an underlying biologic mechanism, most likely genetic variation, that leads to differential fat accumulation. In conclusion, the associations of the HEI-2010 with adiposity were comparable by sex except for the stronger inverse association with high VAT in women. A high diet quality over a 20-year period appeared to have a stronger influence in women than among men. The question of whether these findings are due to true biologic differences or a lack of ability to assess diet quality equally well in men as among women needs to be investigated in future studies.
  3 in total

Review 1.  Nonalcoholic fatty liver disease shows significant sex dimorphism.

Authors:  Xing-Yu Chen; Cong Wang; Yi-Zhou Huang; Li-Li Zhang
Journal:  World J Clin Cases       Date:  2022-02-16       Impact factor: 1.337

2.  Risk factors of overweight/obesity-related lifestyles in university students: Results from the EHU12/24 study.

Authors:  Nerea Telleria-Aramburu; Marta Arroyo-Izaga
Journal:  Br J Nutr       Date:  2021-05-06       Impact factor: 3.718

3.  Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01.

Authors:  Denis Cuany; Fikrey Andetsion; Xavier Fontannaz; Thierry Bénet; Véronique Spichtig; Sean Austin
Journal:  J AOAC Int       Date:  2022-02-04       Impact factor: 1.913

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.